Table 2.

Patient outcome

Patient numberOutcome at last follow-upDays of follow-up (since 1st HSCT)
Full donor, alive and well 987 
Died (aGVHD), full donor Died at day +139 
Re-HSCT, alive and well, full donor 849 
Full donor, alive and well 114 
Full donor, alive and well 485 
aGVHD gr IV (alive and well), full donor 913 
Full donor, alive and well 1,747 
Full donor, alive and well 525 
Alive and well, mixed donor 1,551 
10 Re-HSCT, alive and well, full donor 3,000 
11 Full donor, alive and well 1,370 
12 Graft failure, cGVHD, full donor 160 
13 Full donor, alive with bronchiectasis 799 
14 Full donor, alive and well 428 
15 Full donor, alive and well 791 
16 Graft failure, after second HSCT full donor, poor immune reconstitution 440 
17 Alive with bronchiectasis, mixed donor 1,719 
18 Died (cytopenia and infection), full donor Died at day +75 
19 Full donor, alive and well 1,380 
20 Full donor, alive and well 1,550 
21 Died (graft failure and infection), complete autologous reconstitution Died at day +106 
22 Full donor, alive and well 435 
23 Full donor, alive and well 400 
24 Died (pulmonary transplant-associated microangiopathy), full donor Died at day +130 
25 Died (aGVHD and multi-organ failure), full donor Died at day +73 
26 Full donor, alive and well 270 
27 aGVHD gr IV (currently alive with kidney failure), full donor 3,285 
28 Died (refractory HLH with sepsis and multi-organ failure), full donor Died at day +42 
29 Full donor, alive and well 920 
30 Died (respiratory insufficiency), mixed chimerism Died at day +299 
31 Died (graft failure and infection), full donor Died at day +193 
32 Died (intracranial bleeding), chimerism non-evaluable Died at day +7 
33 Died (graft failure, re-HSCT, infection, and pneumonitis), full donor Died at day +166 
34 Full donor, alive and well 1,582 
35 Full donor, alive and well 1,080 
36 Full donor, alive and well 749 
Patient numberOutcome at last follow-upDays of follow-up (since 1st HSCT)
Full donor, alive and well 987 
Died (aGVHD), full donor Died at day +139 
Re-HSCT, alive and well, full donor 849 
Full donor, alive and well 114 
Full donor, alive and well 485 
aGVHD gr IV (alive and well), full donor 913 
Full donor, alive and well 1,747 
Full donor, alive and well 525 
Alive and well, mixed donor 1,551 
10 Re-HSCT, alive and well, full donor 3,000 
11 Full donor, alive and well 1,370 
12 Graft failure, cGVHD, full donor 160 
13 Full donor, alive with bronchiectasis 799 
14 Full donor, alive and well 428 
15 Full donor, alive and well 791 
16 Graft failure, after second HSCT full donor, poor immune reconstitution 440 
17 Alive with bronchiectasis, mixed donor 1,719 
18 Died (cytopenia and infection), full donor Died at day +75 
19 Full donor, alive and well 1,380 
20 Full donor, alive and well 1,550 
21 Died (graft failure and infection), complete autologous reconstitution Died at day +106 
22 Full donor, alive and well 435 
23 Full donor, alive and well 400 
24 Died (pulmonary transplant-associated microangiopathy), full donor Died at day +130 
25 Died (aGVHD and multi-organ failure), full donor Died at day +73 
26 Full donor, alive and well 270 
27 aGVHD gr IV (currently alive with kidney failure), full donor 3,285 
28 Died (refractory HLH with sepsis and multi-organ failure), full donor Died at day +42 
29 Full donor, alive and well 920 
30 Died (respiratory insufficiency), mixed chimerism Died at day +299 
31 Died (graft failure and infection), full donor Died at day +193 
32 Died (intracranial bleeding), chimerism non-evaluable Died at day +7 
33 Died (graft failure, re-HSCT, infection, and pneumonitis), full donor Died at day +166 
34 Full donor, alive and well 1,582 
35 Full donor, alive and well 1,080 
36 Full donor, alive and well 749 

or Create an Account

Close Modal
Close Modal